The global cholera vaccines market value was USD 120.1 million in 2023, driven by the increasing prevalence of cholera and increased awareness about outbreaks. The market size is anticipated to grow at a CAGR of 12% during the forecast period of 2024-2032 to achieve a value of USD 333.5 million by 2032.
Cholera Vaccines: Introduction
Cholera vaccines are medical products designed to prevent cholera, an acute diarrheal illness caused by the bacterium Vibrio cholerae. The two main types of cholera vaccines widely used are inactivated oral vaccines: Dukoral, which offers additional protection against traveler’s diarrhea caused by ETEC bacteria, and bivalent vaccines like Shanchol and Euvichol. These vaccines work by stimulating the immune system to produce antibodies against the cholera bacteria, thereby providing immunity to individuals who receive them. They are particularly important in cholera-endemic regions and for travelers to areas where cholera is common. The vaccination regimen typically involves multiple doses, and while they provide significant protection, they are most effective when combined with other preventive measures such as improved sanitation, clean water supply, and proper hygiene practices. The development and distribution of cholera vaccines are crucial components of global health efforts to reduce the incidence and impact of cholera outbreaks worldwide.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/cholera-vaccines-market/requestsample
Key Trends in the Global Cholera Vaccines Market
The global market for cholera vaccines has witnessed significant growth in recent years, largely driven by heightened awareness of cholera as a public health threat, particularly in regions with poor sanitation and water infrastructure. The increase in international travel and climate change, contributing to the spread of waterborne diseases, has further spurred demand. The World Health Organization (WHO) has played a pivotal role in this expansion through its prequalification program, which has increased the availability of safe and effective vaccines. Additionally, initiatives like Gavi, the Vaccine Alliance, have facilitated access to vaccines in low-income countries, where cholera outbreaks are more common.
Moreover, advancements in vaccine technology have led to the development of more effective and easier-to-administer oral vaccines, replacing older, less efficient injectable forms. This shift has improved vaccination rates and outreach in remote areas. However, the market is constrained by factors such as limited vaccine production capacity and the need for improved cold chain logistics, particularly in developing countries. Despite these challenges, the cholera vaccine market is expected to continue growing, fueled by increasing government initiatives, international aid, and ongoing efforts to improve vaccine access and distribution globally.
Global Cholera Vaccines Market Segmentations
Market by Product
- Dukoral
- Shanchol
- Vaxchora
- Euvichol
- Others
Market by End User
- Hospitals & Clinics
- Research and Academic Laboratories
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/cholera-vaccines-market
Global Cholera Vaccines Market Overview
The global market for cholera vaccines has experienced steady growth in recent years, primarily driven by increasing awareness, government initiatives, and international efforts to combat outbreaks. Cholera, caused by the Vibrio cholerae bacterium, remains a significant public health concern, especially in regions with inadequate water sanitation, such as parts of Africa, South Asia, and Latin America. The World Health Organization (WHO) and various NGOs have played pivotal roles in promoting vaccination in endemic areas, leading to increased demand for cholera vaccines.
Two main types of vaccines, Dukoral and Shanchol/ Euvichol, dominated the market recently, with both showing effectiveness in controlling outbreaks. The market has also seen innovations in vaccine delivery and formulation, with a focus on enhancing stability and ease of administration. However, challenges persist, including limited production capacity, logistical hurdles in vaccine distribution, and the need for repeat dosing for sustained protection. Additionally, the global cholera vaccine market faces competition from other preventive measures like water purification and sanitation projects. Despite these challenges, the market outlook remains positive, buoyed by continued support from international health organizations and ongoing research and development efforts aimed at improving vaccine efficacy and accessibility.
Global Cholera Vaccines Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Sanofi-aventis Groupe
- Emergent BioSolutions Inc.
- Valneva SE
- GlaxoSmithKline plc.
- Intervet Inc.
- EuBiologics Co., Ltd.
- Astellas Pharma Inc.
- Celldex Therapeutics.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
About Us:
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.
Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.
Media Contact:
Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
